Corner Therapeutics Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 18

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $16.8M

  • Investors
  • 5

Corner Therapeutics General Information

Description

Provider of biotechnology research services intended to stimulate exceptional memory T cells for lifelong immunity. The company's technologies offer a versatile dendritic cell hyperactivation (hDC) platform that induces exceptional T-cell responses, providing robust and durable immunity against a virtually unbounded range of cancers and infectious diseases, enabling healthcare providers to promote durable immunity and ensure the apex of immune regulators.

Contact Information

Website
cornertx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 300 North Beacon Street
  • Building 39, Suite 202
  • Watertown, MA 02472
  • United States
+1 (617)
Primary Industry
Biotechnology
Corporate Office
  • 300 North Beacon Street
  • Building 39, Suite 202
  • Watertown, MA 02472
  • United States
+1 (617)

Corner Therapeutics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Corner Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 20-Oct-2025 $16.8M Completed Pre-Clinical Trials
2. Later Stage VC 11-Aug-2025 Completed Pre-Clinical Trials
1. Grant 01-Nov-2023 $1.77M Completed Startup
To view Corner Therapeutics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Corner Therapeutics Patents

Corner Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026226710-A1 Adjuvant for adoptive cell therapy Pending 23-Apr-2025
WO-2026226703-A1 Lipid nanoparticles loaded with a cyclic gmp-amp synthase (cgas) expression construct, for use in the treatment of a solid tumour Pending 23-Apr-2025
WO-2026207248-A1 Mrna immunomodulators Pending 27-Mar-2025
WO-2026198437-A1 Therapeutic human papillomavirus mrna vaccine and adjuvant for same Pending 17-Mar-2025
WO-2025221606-A1 Lipids for hyperactivation of mammalian dendritic cells Pending 16-Apr-2024 A61K45/06
To view Corner Therapeutics’s complete patent history, request access »

Corner Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Corner Therapeutics Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Cockrell Interests Family Office Minority
Sandia Holdings Corporation Minority
Tanis Venture Management Venture Capital Minority
Ziff Capital Partners Family Office Minority
Gates Foundation Not-For-Profit Venture Capital Minority
To view Corner Therapeutics’s complete investors history, request access »

Corner Therapeutics FAQs

  • When was Corner Therapeutics founded?

    Corner Therapeutics was founded in 2020.

  • Where is Corner Therapeutics headquartered?

    Corner Therapeutics is headquartered in Watertown, MA.

  • What is the size of Corner Therapeutics?

    Corner Therapeutics has 18 total employees.

  • What industry is Corner Therapeutics in?

    Corner Therapeutics’s primary industry is Biotechnology.

  • Is Corner Therapeutics a private or public company?

    Corner Therapeutics is a Private company.

  • What is Corner Therapeutics’s current revenue?

    The current revenue for Corner Therapeutics is .

  • How much funding has Corner Therapeutics raised over time?

    Corner Therapeutics has raised $75.3M.

  • Who are Corner Therapeutics’s investors?

    Cockrell Interests, Sandia Holdings, Tanis Venture Management, Ziff Capital Partners, and Gates Foundation have invested in Corner Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process